MARKET

IMCR

IMCR

Immunocore Holdings Plc
NASDAQ
28.88
-1.06
-3.54%
Pre Market: 28.88 0 0.00% 07:43 11/17 EST
OPEN
30.04
PREV CLOSE
29.94
HIGH
30.48
LOW
28.77
VOLUME
20
TURNOVER
0
52 WEEK HIGH
40.71
52 WEEK LOW
27.50
MARKET CAP
1.49B
P/E (TTM)
-45.0687
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at IMCR last week (1109-1113)?
Weekly Report · 1d ago
Immunocore Holdings Is Maintained at Equal-Weight by Morgan Stanley
Dow Jones · 3d ago
Immunocore Holdings Price Target Cut to $42.00/Share From $43.00 by Morgan Stanley
Dow Jones · 3d ago
Morgan Stanley Maintains Equal-Weight on Immunocore Holdings, Lowers Price Target to $42
Benzinga · 3d ago
Analysts Offer Insights on Healthcare Companies: Immunocore Holdings (IMCR) and Kardigan, Inc. (KARD)
TipRanks · 4d ago
Immunocore price target lowered to $80 from $100 at H.C. Wainwright
TipRanks · 6d ago
Immunocore Holdings Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 11/10 11:58
Immunocore Holdings Price Target Cut to $80.00/Share From $100.00 by HC Wainwright & Co.
Dow Jones · 11/10 11:58
More
About IMCR
Immunocore Holdings plc is a United Kingdom-based commercial-stage biotechnology company. The Company is engaged in the development of TCR bispecific immunotherapies, ImmTAX, which immunes mobilizing monoclonal TCRs against X disease, designed to treat a range of diseases, including cancer, autoimmune and infectious disease. The Company has a pipeline of clinical-stage programs in oncology and infectious diseases, as well as numerous pre-clinical projects. Its lead product, KIMMTRAK, is a TCR therapeutic for the treatment of patients with unresectable or metastatic uveal melanoma (mUM), in the United States, European Union, Canada, Australia and the United Kingdom. Its pipeline products include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-M113V, IMC-I109V, IMC-S118AI, and IMC-U120AI, among others. Its clinical programs are being conducted with patients with a range of cancers including melanoma, ovarian, lung, colorectal and others.

Webull offers Immunocore Holdings PLC - ADR stock information, including NASDAQ: IMCR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IMCR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IMCR stock methods without spending real money on the virtual paper trading platform.